Stay updated on Sotatercept in PAH High-Risk Mortality Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.

Latest updates to the Sotatercept in PAH High-Risk Mortality Clinical Trial page
- ChecktodayChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of topics related to drug safety and high blood pressure prevention. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%
- Check7 days agoChange DetectedThe webpage has been updated to include new study results and publications related to the effects of sotatercept on pulmonary arterial hypertension, with specific details on participant eligibility, treatment protocols, and outcome measures. Notably, the results posting date has been updated to August 22, 2025.SummaryDifference46%
- Check14 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
- Check36 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
Stay in the know with updates to Sotatercept in PAH High-Risk Mortality Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.